Century Therapeutics, a cell therapy company developing cell therapies for cancer, recently announced it plans to expand its operations and laboratory space in Philadelphia.
The expansion will help the company increase its in-house research and development capabilities.
The company will open in multiple uCity Square locations near its 3675 Market Street headquarters. This includes a 25,000-square-foot space, a 5,000-square-foot space, 17,000-square-feet of mixed office and laboratory space, and a commitment for 33,000-square-feet to be used as life sciences development.
“We are excited to expand our footprint within the heart of Philadelphia – which has emerged as an epicenter of the growing cell and gene therapy field,” Century Therapeutics CEO Lalo Flores said. “This new space will not only boost community vitality and fuel the local economy, but it will also enable us to accelerate development of our genetically engineered, universal iPSC (pluripotent stem cell)-derived immune effector cell products – including iNK and iT cells – and ultimately reach more cancer patients.”
The company also plans to expand its manufacturing facility in New Jersey. It will build a 53,000-square-foot facility in Branchburg for its in-house Current Good Manufacturing Practice manufacturing, supply a pipeline of cellular products, and supplement existing privileged access to the Fujifilm Cellular Dynamics facilities.